ArticleFrontiers in medicine2025
Impact of socioeconomic status on chronic obstructive pulmonary disease prognosis: a national cohort study.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Incidence and outcomes of patients hospitalised with COPD in Greater Glasgow and Clyde, Scotland 2015-2022: a retrospective cohort study.BMC pulmonary medicine · 2026Article
- Psychological-Symptom Mismatch Phenotypes and Their Clinical Implications in Patients with Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2026Article
- Chronic Obstructive Pulmonary Disease in Never-Smokers-A Distinct Entity Within the COPD Spectrum.Life (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a major cause of global morbidity and mortality, with socioeconomic status (SES) playing a significant role in disease outcomes. While the impact of individual SES on COPD has been reported, the influence of both individual and neighborhood SES on clinical outcomes remains unclear. We aimed to evaluate the association between SES and COPD outcomes. Method: We conducted a retrospective cohort study using 2015-2018 data from the Korean National Health Insurance Service-National Sample Cohort, linked with census data. SES was assessed at both individual (income, insurance type) and neighborhood levels (residential area, elderly proportion, education level, gross regional domestic product, and total population density). Outcomes included overall mortality and hospitalization, which were evaluated using Cox proportional hazard models adjusted for demographic and air pollution. Results: Among 12,820 patients (mean age 63.5 years, 47.2% male), higher income was significantly associated with lower mortality risk (hazard ratio [HR] = 0.961, 95% confidence interval [CI] = 0.936-0.986) in the adjusted model. Suburban residence was associated with increased mortality risk (HR = 1.432, 95% CI = 1.089-1.884), while rural residence was not significant after adjustment. For hospitalization, higher income was also significantly associated with a lower risk (HR = 0.987, 95% CI = 0.979-0.995). Suburban (HR = 1.097, 95% CI = 1.013-1.187) and rural (HR = 1.138, 95% CI = 1.046-1.239) residence also remained significantly associated with increased hospitalization risk in the adjusted models. Additionally, a higher proportion of older adults (HR = 1.010, 95% CI = 1.004-1.016) and lower educational attainment (HR = 0.992, 95% CI = 0.989-0.995) were also significantly associated with hospitalization risk. Conclusion: These findings suggest that individual SES is associated with both mortality and hospitalization among patients with COPD, while neighborhood SES influences hospitalization but not mortality after adjustment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.